/PETQ

PETQ Stock - PetIQ, Inc.

Q: What is the analyst price target for PETQ?

Analyst price target information is not currently available for PETQ.

Q: What is PETQ's market cap?

Market capitalization information is not currently available for PETQ.

Healthcare|Drug Manufacturers - Specialty & Generic|NASDAQ

$30.98-0.03%

$0.01 (-0.03%) • Oct 24

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+0.1%upside

Target: $31.01

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for PETQ

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.74

52W High$31.06

52W Low$15.09

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	$1.10B	$921.51M	$932.53M	$780.05M	$709.43M
Gross Profit	$252.74M	$209.66M	$186.39M	$135.19M	$107.38M
Gross Margin	22.9%	22.8%	20.0%	17.3%	15.1%
Operating Income	$60.02M	$27.23M	$15.87M	$-2,616,000	$4.36M
Net Income	$2.13M	$-48,620,000	$-16,383,000	$-81,022,000	$-14,302,000
Net Margin	0.2%	-5.3%	-1.8%	-10.4%	-2.0%
EPS	$0.07	$-1.67	$-0.58	$-3.29	$-0.63

Company Overview

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at 2,900 community clinics and wellness centers hosted at pet retailers across 42 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

67%

Hold / Neutral

33%

Sell / Underperform

Analyst Consensus🟡 Mixed

2 Bullish1 Neutral/Bearish

Price Targets

$27

Average Target

↓ 12.8% Downside

Now

$22

Low

$27

Average

$31

High

Based on 3 analysts

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
August 8th 2024	Truist	Downgrade	Hold	$31← $30
December 19th 2023	Jefferies	Initiation	Buy	$22
September 6th 2023	Lake Street	Initiation	Buy	$28
May 13th 2022	Oppenheimer	Downgrade	Perform	-

Earnings History & Surprises

PETQ

Beat Rate

70%

Last 20 quarters

Avg Surprise

+94.2%

EPS vs Estimate

Beats / Misses

14/5

1 met exactly

Latest EPS

$0.32

Q4 2024

EPS Surprise History

Q1 23

+37.5%

$-0.10vs$-0.16

Q2 23

+28.6%

$0.45vs$0.35

Q3 23

+76.9%

$0.46vs$0.26

Q4 23

+2300.0%

$0.42vs$0.02

Q1 24

+58.6%

$-0.12vs$-0.29

Q2 24

+34.9%

$0.58vs$0.43

Q3 24

+42.9%

$0.70vs$0.49

Q4 24

-34.7%

$0.32vs$0.49

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2024	Nov 5, 2024	$0.49	$0.32	-34.7%	✗ MISS
Q3 2024	Aug 7, 2024	$0.49	$0.70	+42.9%	✓ BEAT
Q2 2024	May 8, 2024	$0.43	$0.58	+34.9%	✓ BEAT
Q1 2024	Feb 28, 2024	$-0.29	$-0.12	+58.6%	✓ BEAT
Q4 2023	Nov 7, 2023	$0.02	$0.42	+2300.0%	✓ BEAT
Q3 2023	Aug 8, 2023	$0.26	$0.46	+76.9%	✓ BEAT
Q2 2023	May 9, 2023	$0.35	$0.45	+28.6%	✓ BEAT
Q1 2023	Feb 28, 2023	$-0.16	$-0.10	+37.5%	✓ BEAT
Q4 2022	Nov 9, 2022	$0.06	$0.15	+150.0%	✓ BEAT
Q3 2022	Aug 9, 2022	$0.34	$0.51	+50.0%	✓ BEAT
Q2 2022	May 4, 2022	$0.37	$0.62	+67.6%	✓ BEAT
Q1 2022	Mar 1, 2022	$-0.01	$-0.02	-155.4%	✗ MISS
Q4 2021	Nov 3, 2021	$0.10	$0.10	0.0%	= MET
Q3 2021	Aug 4, 2021	$0.73	$0.65	-11.0%	✗ MISS
Q2 2021	May 5, 2021	$0.13	$0.39	+200.0%	✓ BEAT
Q1 2021	Feb 25, 2021	$-0.12	$-0.10	+16.7%	✓ BEAT
Q4 2020	Nov 5, 2020	$0.16	$-0.11	-168.8%	✗ MISS
Q3 2020	Aug 6, 2020	$0.44	$0.70	+59.1%	✓ BEAT
Q2 2020	May 7, 2020	$0.17	$0.19	+11.8%	✓ BEAT
Q1 2020	Mar 10, 2020	$0.06	$-0.47	-880.6%	✗ MISS

Frequently Asked Questions about PETQ

What is PETQ's current stock price?

PetIQ, Inc. (PETQ) is currently trading at $30.98 per share. The stock has moved -0.03% today.

What is the analyst price target for PETQ?

The average analyst price target for PETQ is $31.00, based on 1 analyst.

What sector is PetIQ, Inc. in?

PetIQ, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the NASDAQ exchange.

What is PETQ's market cap?

PetIQ, Inc. has a market capitalization of $0.92 billion, making it a small-cap company.

Does PETQ pay dividends?

No, PetIQ, Inc. does not currently pay a dividend to shareholders.